1,800
Participants
Start Date
October 1, 2025
Primary Completion Date
February 2, 2027
Study Completion Date
February 2, 2028
3-step Assess-Advice-Refer
Four implementation strategies will be conducted individually for each of the study unit at the timepoint when the study unit is being randomly allocated to the implementation condition. For each study unit, all site facilitators will first receive a half-day training. Each study unit under the implementation condition will receive weekly audit and feedback reports to summarize the proportion of eligible patients, proportion of eligible patients being screened, proportion of patients appropriately referred to JCICC. The senior research assistant with a nursing background will receive training and mentoring from the PI and will be the guided facilitator. The guided facilitator will conduct weekly site visits to address operational issues arise during the implementation. Lastly, while the FitARise protocol is standardized and cannot be modified, the routine workflow for each study unit can be adjusted according to its context and resources.
KWH Department of Surgery, Hong Kong
PMH Department of Oncology, Hong Kong
PYEH Department of Clinical Oncology, Hong Kong
QMH Department of Clinical Oncology, Hong Kong
QMH Department of Obstetrics and Gynaecology, Hong Kong
QMH Department of Surgery, Hong Kong
TMH Department of clinical oncology, Hong Kong
YCH Surgery Department, Hong Kong
The University of Hong Kong
OTHER